Van Lanschot Kempen Logo
Search
Van Lanschot Kempen Logo
Search
Apr 2014
mainstay
Joint Global Coordinator & Joint Bookrunner
€ 18.8 million
Initial Public Offering

Mainstay

Mainstay Medical is an Irish medical technology company aiming to treat chronic low back pain by using their active implantable device ReActiv8

  • Mainstay Medical floated on Euronext Paris and the Enterprise Securities Market of the Irish Stock Exchange
  • Proceeds of the IPO will be used to conduct clinical trials and to obtain CE mark approval
  • Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner and placed 41.6% of the shares with US investors